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Introducing the Cardiovascular, metabolic and lipoprotein translation section of journal of translational medicine.The Journal of Translational Medicine has focused on all
areas of translational medicine derived from human
experimentation to facilitate the communication between
basic and clinical science. As the obesity, diabetes and
cardiovascular disease epidemic continues to rise, espe-
cially with industrialization of developing countries [1],
there is great need to focus on disseminating information
between scientists and clinicians within this ‘cardiometa-
bolic arena’. Despite aggressive control of cardiovascular
disease risk factors, residual risk [2] related to untreated
or undiscovered pathways demonstrate the need for
intensive research and communication in this field.
Indeed the thrust to discover novel pathways for thera-
peutics within the cardiometabolic arena is accelerating
rapidly with the continued advent of technologies in ge-
nomics [3], biological assays [4] and collaborative science
[5]. T1 translation [6] strives to connect basic science re-
search to clinical research and has a strong foundation
with a long history of wet lab experimentation. Basic
scientists have a rich array of forums and journals in
which they can disseminate their findings. Additionally,
T2 translation revolves around the goal of bridging re-
search into everyday clinical practice and health decision
making, and includes guideline development, meta-
analyses, and systematic reviews. A wide number of jour-
nals which are geared toward practitioners exist to
facilitate communication within these fields. Finally, T3
includes dissemination and implementation research
which includes policy-making and population-focusedCorrespondence: nehal.mehta@nih.gov
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However, groups performing cardiometabolic and
lipoprotein-based multi-disciplinary, translational re-
search between the T1 and T2 phases often struggle to
find an appropriate target journal to publish their find-
ings because of the mixed content of basic and clinical
research. This mismatch often delays publication of im-
portant findings due to the combination of multiple sub-
missions to basic science and clinical journals. In order
to increase the speed at which discoveries move from
the lab into the clinic, ultimately improving the health of
populations, fast and efficient communication is essen-
tial to keep up with these moving targets. Therefore, we
here introduce the section of Cardiovascular, metabolic
and lipoprotein translation within the Journal of Trans-
lational Medicine, which is devoted to the rapid publica-
tion of research papers within these fields.
This section aims to speed mechanistic understanding,
development of novel diagnostics and potential thera-
peutic targets within cardiovascular, metabolic diseases
and lipoprotein diseases. We are open to experiments
involving cellular models, animal models, observational
studies and clinical trials that are distinguished for their
novelty in approach, design or indication, timeliness,
and unique ability to translate laboratory concepts from
the bench to the bedside. Highest priority will be given
to those manuscripts which are specifically focused on
cardiovascular, metabolic and lipid disorders which en-
rich understanding of disease mechanism, novel thera-
peutics and state-of-the-art scientific technique.
We invite your group to consider publishing your find-
ings within this exciting new section which will behis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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within cardiovascular medicine, lipoprotein biology,
endocrinology, metabolism, animal biology, basic science
and human genomics.
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